A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an exploratory study to determine effectiveness of Elidel for the treatment of seborrheic dermatitis

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Dermatology Specialists Research
• Collaborator: Novartis
• Treatments: Pimecrolimus

Criteria

Inclusion Criteria:

• Must be 18 or older and sign written informed consent.

• Must be wiling and able to comply with protocol.

• Must have active seborrheic dermatitis of the face.

Exclusion Criteria:

• No history of overt bacterial, viral or fungal infection of the head/neck.

• No history or presence of compromising dermatosis elsewhere on the skin

• No Parkinson's disease, HIV, infections or disorders of the central nervous system

• No actinically damaged skin